NDC 61703-327

Dacarbazine

Dacarbazine

Dacarbazine is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Dacarbazine.

Product ID61703-327_9836bc8d-c770-48a0-86c5-806085dd52ea
NDC61703-327
Product TypeHuman Prescription Drug
Proprietary NameDacarbazine
Generic NameDacarbazine
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2003-07-01
Marketing CategoryANDA / ANDA
Application NumberANDA075940
Labeler NameHospira, Inc.
Substance NameDACARBAZINE
Active Ingredient Strength10 mg/mL
Pharm ClassesAlkylating Activity [MoA],Alkylating Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 61703-327-22

1 VIAL in 1 CARTON (61703-327-22) > 20 mL in 1 VIAL
Marketing Start Date2003-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61703-327-22 [61703032722]

Dacarbazine INJECTION, POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA075940
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2003-07-01

Drug Details

Active Ingredients

IngredientStrength
DACARBAZINE10 mg/mL

OpenFDA Data

SPL SET ID:4c7e5795-feba-425d-7ca3-6cb2c3a1c43c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1731338
  • Pharmacological Class

    • Alkylating Activity [MoA]
    • Alkylating Drug [EPC]

    NDC Crossover Matching brand name "Dacarbazine" or generic name "Dacarbazine"

    NDCBrand NameGeneric Name
    0143-9245DacarbazineDacarbazine
    0703-5075DacarbazineDacarbazine
    61703-327DacarbazineDACARBAZINE
    63323-127DacarbazineDACARBAZINE
    63323-128DacarbazineDACARBAZINE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.